Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 1022-1026. doi: 10.19723/j.issn.1671-167X.2018.06.014
• Article • Previous Articles Next Articles
Sheng-guang LI1,△(
),Qing ZHANG2,Hui-qiong ZHOU2
CLC Number:
| [1] |
Jennette JC, Falk RJ, Bacon PA , et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides[J]. Arthritis Rheum, 2013,65(1):1-11.
doi: 10.1002/art.37715 pmid: 23045170 |
| [2] | Yates M, Watts RA, Bajema IM , et al. EULAR/ERA-EDTA re-commendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016,75(9):1583-1594. |
| [3] |
Lanham JG, Elkon KB, Pusey CD , et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome[J]. Medicine, 1984,63(2):65-81.
doi: 10.1097/00005792-198403000-00001 |
| [4] |
Masi AT, Hunder GG, Lie JT , et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)[J]. Arthritis Rheum, 1990,33(8):1094-1100.
doi: 10.1002/art.1780330806 pmid: 2202307 |
| [5] | Leavitt RY, Fauci AS, Bloch DA , et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis[J]. Arthritis Rheum, 1990,33(8):1101-1107. |
| [6] | Watts R, Lane S, Hanslik T , et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiolo-gical studies[J]. Ann Rheum Dis, 2007,66(2):222-227. |
| [7] | Luqmani RA, Bacon PA, Moots RJ , et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis[J]. QJM, 1994,87(11):671. |
| [8] |
Eisenberger U, Fakhouri F, Vanhille P , et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome[J]. Nephrol Dial Transplant, 2005,20(7):1392-1399.
doi: 10.1093/ndt/gfh830 |
| [9] |
Stone JH, Hoffman GS, Merkel PA , et al. A disease-specific activity index for Wegener’s granulomatosis: modification of the Birmingham vasculitis activity score[J]. Arthritis Rheum, 2001,44(4):912-920.
doi: 10.1002/(ISSN)1529-0131 |
| [10] |
Exley AR, Bacon PA, Luqmani RA , et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides[J]. Arthritis Rheum, 2014,40(2):371-380.
doi: 10.1002/art.1780400222 pmid: 9041949 |
| [11] |
De GK, Gross WL, Herlyn K , et al. Development and validation of a disease extent index for Wegener’s granulomatosis[J]. Clin Nephrol, 2001,55(1):31-38.
pmid: 11200865 |
| [12] |
Guillevin L, Lhote F, Gayraud M , et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients[J]. Medicine, 1996,75(1):17-28.
doi: 10.1097/00005792-199601000-00003 |
| [13] |
Guillevin L, Pagnoux C, Seror R , et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort[J]. 2011,90(1):19-27.
doi: 10.1097/MD.0b013e318205a4c6 pmid: 21200183 |
| [14] |
Moiseev S, Novikov P, Jayne D , et al. End-stage renal disease in ANCA-associated vasculitis[J]. Nephrol Dial Transplant, 2017,32(2):248-253.
doi: 10.1093/ndt/gfw046 pmid: 27190338 |
| [15] |
Greenan K, Vassallo D, Chinnadurai R , et al. Respiratory manifestations of ANCA-associated vasculitis[J]. Clin Respir J, 2018,12(1):57-61.
doi: 10.1111/crj.12478 pmid: 27059787 |
| [16] |
Frausova D, Hruskova Z, Lanska V , et al. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study[J]. Arthritis Res Ther, 2016(18):168.
doi: 10.1186/s13075-016-1055-5 pmid: 4944267 |
| [17] | 张清, 周惠琼, 郭娟 , 等. 抗中性粒细胞胞质抗体相关性血管炎死亡危险因素的探讨[J]. 中华医学杂志, 2017,97(43):3392-3395. |
| [1] | Lingfu ZHANG, Ming CHEN, Xiaoyu ZHAO, Gang WANG, Long CUI, Xiaofeng LING, Lixin WANG, Zhi XU, Limei GUO, Chunsheng HOU. Gross classification of gallbladder cancer with primary lesion limited to the gallbladder wall and its correlation with prognosis and precancerous lesions [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 184-189. |
| [2] | Boda GUO, Min LU, Guoliang WANG, Hongxian ZHANG, Lei LIU, Xiaofei HOU, Lei ZHAO, Xiaojun TIAN, Shudong ZHANG. Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 644-649. |
| [3] | Weihao LI, Jing LI, Xuemin ZHANG, Wei LI, Qingle LI, Xiaoming ZHANG. Effect of intraoperative blood salvage autotransfusion on the prognosis of patients after carotid body tumor resection [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 272-276. |
| [4] | Yaqing MAO, Zhen CHEN, Yao YU, Wenbo ZHANG, Yang LIU, Xin PENG. Impact of type 2 diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1089-1096. |
| [5] | Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588. |
| [6] | Shuai LIU,Lei LIU,Zhuo LIU,Fan ZHANG,Lulin MA,Xiaojun TIAN,Xiaofei HOU,Guoliang WANG,Lei ZHAO,Shudong ZHANG. Clinical treatment and prognosis of adrenocortical carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 624-630. |
| [7] | Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666. |
| [8] | Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679. |
| [9] | Yangyi FANG,Qiang LI,Zhigao HUANG,Min LU,Kai HONG,Shudong ZHANG. Well-differentiated papillary mesothelial tumour of the tunica vaginalis: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 741-744. |
| [10] | Yuanyuan ZENG,Yun XIE,Daonan CHEN,Ruilan WANG. Related factors of euthyroid sick syndrome in patients with sepsis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 526-532. |
| [11] | Jian-bin LI,Meng-na LYU,Qiang CHI,Yi-lin PENG,Peng-cheng LIU,Rui WU. Early prediction of severe COVID-19 in patients with Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1007-1012. |
| [12] | Huan-rui LIU,Xiang PENG,Sen-lin LI,Xin GOU. Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 793-801. |
| [13] | Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811. |
| [14] | Han LU,Jian-yun ZHANG,Rong YANG,Le XU,Qing-xiang LI,Yu-xing GUO,Chuan-bin GUO. Clinical factors affecting the prognosis of lower gingival squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 702-707. |
| [15] | Yun-fei SHI,Hao-jie WANG,Wei-ping LIU,Lan MI,Meng-ping LONG,Yan-fei LIU,Yu-mei LAI,Li-xin ZHOU,Xin-ting DIAO,Xiang-hong LI. Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 521-529. |
|
||